Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Klin Mikrobiol Infekc Lek ; 24(1): 14-16, 2018 03.
Artículo en Checo | MEDLINE | ID: mdl-30016534

RESUMEN

Presented are two cases of vascular prosthesis infections complicated by peritonitis with a lethal course. The authors describe complicated antibiotic therapy with findings, exhausted options for surgical therapy and subsequent decision that the condition was untreatable and palliative care was initiated.


Asunto(s)
Prótesis Vascular/efectos adversos , Infecciones Relacionadas con Prótesis/patología , Antibacterianos/uso terapéutico , Resultado Fatal , Humanos
2.
New Microbiol ; 34(3): 291-8, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21811750

RESUMEN

Pseudomonas aeruginosa is one of the most frequent and dangerous pathogens involved in the etiology of severe nosocomial infections. A retrospective observational study was conducted at all intensive care units of the University Hospital in Olomouc, Czech Republic (155 ICU beds). Complete antibiotic utilization data of the ICUs in the period of 1999 to 2008 were processed according to ATC/DDD system and expressed in defined daily doses per 100 bed-days (DBD). Utilization of meropenem, imipenem, ciprofloxacin, ofloxacin, pefloxacin, gentamicin, amikacin, ceftazidime, cefoperazone, cefoperazone/sulbactam and piperacillin/tazobactam was measured. Pseudomonas aeruginosa strains were isolated from clinical material obtained from patients hospitalized in ICUs. During the ten-year period, utilization of the entire group of antibiotics monitored grew. It increased from 23.52 DBD in 1999 to 27.48 DBD in 2008 with a peak of 33.04 DBD in 2007. P. aeruginosa accounted for as much as 42% of pneumonias and 23% of surgical wound infections. Our results show that P. aeruginosa strains became gradually resistant to all antibiotics used in the treatment of the infections caused by them, with the exception of amikacin and piperacillin/tazobactam.


Asunto(s)
Antibacterianos/farmacología , Unidades de Cuidados Intensivos , Pseudomonas aeruginosa/efectos de los fármacos , Amicacina/farmacología , Cefoperazona/farmacología , Ceftazidima/farmacología , Ciprofloxacina/farmacología , República Checa , Farmacorresistencia Bacteriana Múltiple , Gentamicinas/farmacología , Pruebas de Sensibilidad Microbiana , Ácido Penicilánico/análogos & derivados , Ácido Penicilánico/farmacología , Piperacilina/farmacología , Sulbactam/farmacología , Tazobactam
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...